Zimmer Biomet Holdings Business Model

Introduction

Zimmer Biomet is a publicly held corporation based in Warsaw, Indiana. In November 2014, it was announced that Biomet will be acquired by rival Zimmer Holdings for $13 billion. The merger was completed on June 15, 2015. After the merger, the new company is named Zimmer Biomet.

Zimmer Holdings Inc. is an American medical device company. The company designs, manufactures and markets reconstructive products; orthopaedic, neurological, wound care and dental devices; and minimally invasive surgical products. They are a global leader in musculoskeletal healthcare.

Zimmer Biomet is a publicly held corporation based in Warsaw, Indiana. In November 2014, it was announced that Biomet will be acquired by rival Zimmer Holdings for $13 billion.

The company designs, manufactures and markets reconstructive products; orthopaedic, neurological, wound care and dental devices; and minimally invasive surgical products. The company has more than 33000 employees worldwide (including its affiliates). It also has manufacturing facilities located in Australia & New Zealand; Brazil; Canada; China & Hong Kong SAR China; France; Germany & Austria (Europa); Italy & Spain (Euroco); Japan; Mexico & Latin America (Olmec); Poland (Biomed Polska); Russia & Ukraine (Biomed Moscow) South Korea(Biomed Seoul); Sweden(Biomed Sweden).

Zimmer Holdings Inc offers the following solutions:

• Surgical Orthopaedics: This segment offers solutions for patients experiencing pain or dysfunction due to arthritis, trauma, or congenital conditions such as scoliosis.
• Spine: Zimmer Holdings Inc offers a portfolio of products designed to treat degenerative conditions in the spine including spinal fusion components and instrumentation for minimally invasive surgery.
• Sports Medicine and Joint Preservation: The company provides products for joint preservation procedures which are designed to help treat osteoarthritis or repair arthritic joints without surgery.
• Trauma: This segment offers orthopedic trauma products used in treating fractures and dislocations resulting from traumatic accidents such as automobile crashes, falls, sports injuries etcetera.
• Neurology: Zimmer Holdings Inc provides implantable neurostimulation devices which are used in the treatment of neurological disorders such as Parkinson’s disease (PD), essential tremor (ET), epilepsy etcetera

Section: Surgical Orthopaedics

What is Zimmer Biomet Holdings?

Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, with a focus on developing and marketing implants such as artificial knees and hips. The company’s products are used to treat joint disorders such as arthritis, osteoarthritis and traumatic injury to the bones or soft tissues of the spine. In addition to these devices, Zimmer Biomet also offers patient care solutions including surgical instruments for orthopedic surgery, biologics and pharmaceuticals for bone regeneration.

The company’s history dates back almost 100 years when founder Paul Mollinger started making bone pins in his garage in Germany during World War I; however it wasn’t until 1984 that he founded what would become Zimmer Biomet Holdings Inc.. In 1992 Mollinger sold his shares of the family business which became known as Zimmer Inc., later rebranded as Medtronic Sofamor Danek Spine LLC after being purchased by Medtronic PLC in 2005 (now Medtronic Spine).

Section: Spine

Globally, Zimmer Biomet Holdings is a leader in musculoskeletal healthcare. The company designs, manufactures and markets reconstructive products; orthopaedic, neurological, wound care and dental devices; and minimally invasive surgical products.

Zimmer Biomet Holdings sells its products through a network of sales representatives and business partners to hospitals (including hospitals within hospital systems), surgical centers, distributors such as independent medical equipment companies, physical medicine/rehabilitation clinics and other healthcare providers in more than 100 countries around the world.

Section: Sports Medicine and Joint Preservation

$ZBH is a market leader in the development and manufacturing of orthopedic devices. Founded in 1961 by brothers-in-law John W. Zimmer and Richard H. Biomet, $ZBH has since evolved into one of the largest publicly-traded medical device companies in the world.

To date, Zimmer Biomet offers a variety of solutions for sports medicine and joint preservation.

Section: Trauma

The trauma business is one of Zimmer Biomet’s three core businesses, along with spine and extremities. The company markets products for some of the most serious injuries that can occur during an accident or sporting event.

The Trauma segment includes all sales of products used in orthopedic surgery and patient care as well as related services, such as surgical kits and instruments. In addition to its own branded products, Zimmer Biomet distributes other manufacturers’ products through its distribution network. This includes a range of devices that are used to support healing after trauma surgeries such as the fusion process following spinal cord injury or joint replacement procedures like hip replacements following arthritis.

Section: Neurology

The Neurology business provides surgeons with biometically engineered, innovative technologies to help treat neurological disorders such as spinal deformities and degenerative joint disease. The company’s portfolio includes products that are used in surgery, as well as products used for rehabilitation after surgery.

Neurological disorders are medical conditions that affect the brain, spinal cord, and the nerves that connect them.

Examples of neurological disorders include: Alzheimer’s disease; chronic pain syndromes; epilepsy; hydrocephalus (excess fluid on the brain); intracranial hypertension (increased pressure inside the head); multiple sclerosis; muscular dystrophies (progressive muscle diseases); Parkinson’s disease; restless legs syndrome; spinal cord injuries; stroke

Zimmer Biomet is a publicly held corporation based in Warsaw, Indiana. In November 2014, it was announced that Biomet will be acquired by rival Zimmer Holdings for $13 billion. The merger was completed on June 15, 2015. After the merger, the new company is named Zimmer Biomet.

Zimmer Biomet is one of the top medical device manufacturers in the world and serves surgeons worldwide through its global sales force and distribution network composed of independent distributors, resellers and partners

Conclusion

In conclusion, this business model has shown that it can be extremely profitable and successful in today’s market. It is also a model that we as investors should always keep in mind when looking at potential investments in companies that have good products and services to offer their customers.